Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

A new serum aims to clear acne and boost skin confidence

NCT ID NCT07752368

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This trial tests a topical serum containing 0.5% salicylic acid in adults with acne-prone skin. Over eight weeks, participants apply the serum as directed and report changes in acne symptoms, skin texture, tone, and more. The study uses questionnaires and expert photo grading to see if the serum makes a visible difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A topical serum containing 0.5% salicylic acid
What this could lead to
If successful, this serum could offer a simple, over-the-counter option to ease acne symptoms and improve skin appearance and quality of life.
What could go wrong
This is a small, early-stage study without a placebo group, so results may not prove the serum works better than no treatment. Individual results can vary, and the serum may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

25 people

The number who actually took part.

Started

Jun 2023

Finished

Aug 2023

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

24 to 47 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female between the ages of 24-47 (between 2-4 males, the remainder females) * Actively has acne (non-inflamed and/or inflamed acne) * Has previously used or is currently using exfoliating acids (AHAs / BHA) and is willing to stop this for the duration of the study * Has not experienced sunburn on the face in the last month * No open wounds, sores, or non-acne related lesions on the face * Generally healthy - don't live with any uncontrolled chronic disease * Willing to apply SPF on a daily basis during the study and to use other sun protection on the face (i.e. a hat) * Must be willing to avoid products with coconut oil and shea butter, and Ethylhexyl Palmitate for the duration of the study * Must be willing to cut out whey protein and cow's milk from their diet for the duration of the study * Must be willing to avoid biotin products or supplements for the duration of the study * Must agree to avoid sun tanning, tanning beds, and self-tanning products for the duration of the study Exclusion Criteria: * Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders * Anyone with known severe allergic reactions * Women who are pregnant, breastfeeding or attempting to become pregnant * Unwilling to follow the study protocol * Smoker * Anyone consuming products containing Tetrahydrocannabinol (THC) * Identifies as a person with sensitive skin * Anyone currently on steroids or undergoing hormone replacement therapy * Anyone using prescription medication relevant to the skin * Undergoing any cosmetic procedures during the study including facials, Botox, dermal filler, laser, or chemical peel treatments * Use of prescription drug (topical or oral) that is targeted at any sort of skin condition (e.g., retinoids, accutane) * Anyone allergic to niacinamide or salicylic acid * Anyone who regularly consumes biotin supplements and is unwilling to stop for the duration of the study * Participants who stopped using birth control within the past 3 months * Participants currently have a Copper IUD or are using one of the following birth control high in androgen and low in estrogen activity: Amethyst, Jolessa, Lessina, Levonest/Levora, Lutera, Nordette, Portia, Seasonale/Seasonique, Sronyx, Mirena IUD, Triphasil/Trivora, Cryselle, Lo-Ovral/Ovral, Low-Ogestrel/Ogestrel, Lo-Feminol, Ortho tricyclen Lo, Estrostep Fe, Loestrin, Microgestin, Apri, Mircette, Azurette, Caziant, Cyclessa, Desogen, Emoquette, Kariva, Linessa, Marvelon, NuvaRing, Depo-Provera, Reclipsen

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acne are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acne Acne Vulgaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Citruslabs

    Las Vegas, Nevada, 89101, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.